Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q1 2018 call → NOWe need to determine if management explains where the company's business is going by narrating what its counterparties are themselves doing and scaling. The key is whether management's forward account is substantially about the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, licensees, distributors, payers, operators, or programs the company already supplies or serves, such that the company's own coming volume is presented as a consequence of those parties' own trajectories. Let's analyze the transcript. The call covers Q1 2018 results. Management discusses several topics: acquisition of Biosynthetic Technologies, ERP implementation, self-help initiatives, crude optimization, and segment performance. The forward-looking statements are about expected strengthening in Q2, pricing adjustments, crude optimization, and self-help benefits. There is also discussion about the Biosynthetic Technologies acquisition and its potential. The question asks: does management explain where the company's business is going by narrating what its counterparties are themselves doing and scaling? That is, does management report on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, etc., that the company already supplies or serves, such that the company's own coming volume is presented as a consequence of those parties' own trajectories? Looking at the transcript, management talks about the Biosynthetic Technologies acquisition. They mention that they have a new product innovation center, and they are pursuing third-party commercial involvement. They talk about potential markets: automotive, industrial, marine, personal care. But they do not describe specific counterparties' own ramps or launches. They talk about the technology and its potential, but not about specific customers or partners scaling up. They mention that they are actively pursuing third-party commercial involvement, but that is about seeking partners, not about existing counterparties' growth. They also discuss crude optimization, like running more Midland WTI, but that is about their own sourcing, not about counterparties. They discuss self-help initiatives, which are their own actions. They discuss ERP implementation, which is internal. They discuss expected stronger performance in Q2 due to seasonality and less turnaround.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.